Delaware
|
|
001-33497
|
|
71-0869350
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock Par Value $0.01
|
FOLD
|
NASDAQ
|
1.
|
Election of Directors.
|
Nominee
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
John F. Crowley
|
189,880,915
|
5,135,375
|
14,252,899
|
Margaret G. McGlynn
|
193,143,570
|
1,872,720
|
14,252,899
|
Michael G. Raab
|
190,321,655
|
4,694,635
|
14,252,899
|
Glenn P. Sblendorio
|
144,220,880
|
50,795,410
|
14,252,899
|
Votes For
|
Votes Against
|
Votes Abstain
|
Broker Non-Votes
|
182,264,565
|
3,221,793
|
9,529,932
|
14,252,899
|
Votes For
|
Votes Against
|
Votes Abstain
|
Broker Non-Votes
|
208,447,873
|
709,641
|
111,675
|
—
|
4.
|
Approval, on an advisory basis, of the Company’s executive compensation.
|
Votes For
|
Votes Against
|
Votes Abstain
|
Broker Non-Votes
|
191,219,270
|
3,722,897
|
74,123
|
14,252,899
|
|
AMICUS THERAPEUTICS, INC.
|
Date: June 27, 2019
|
By: /s/ Ellen S. Rosenberg
|
|
Name: Ellen S. Rosenberg
|
|
Title: Chief Legal Officer and Corporate Secretary
|